Hologram Quantitative Structure-Activity Relationships Investigations of Non-nucleoside Reverse Transcriptase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|17|1661-1677

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.17, 2003-09, pp. : 1661-1677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors

By Smith P.F.  

Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. : 893-905

Adis International

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M.   Morrison I.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

Hologram Quantitative Structure-Activity Relationships for a Class of Inhibitors of HIV-1 Protease

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 5, 2007-07 ,pp. : 356-364

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors

By Ma Qing   Okusanya Olanrewaju O   Smith Patrick F   DiCenzo Robert   Slish Judianne C   Catanzaro Linda M   Forrest Alan   Morse Gene D  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 473-485

Informa Healthcare

Access to resources Recommend Favorite